HIV and Hepatitis.com Coverage of the
41st Annual Meeting of the European Association
for the Study of the Liver (41st EASL)
April 26 - 30, 2006, Vienna, Austria



Liver Transplantation


HIV INFECTED PATIENTS LISTED FOR LIVER TRANSPLANTATION HAVE SHORTER INTENTION-TO-TREAT SURVIVAL THAN NON-INFECTED PATIENTS.
C Sanz. Abstract 162.

MULTICENTER RANDOMIZED TRIAL OF HCV TREATMENT WITH PEGINTERFERON-ALFA 2A AND RIBAVIRIN IN LIVER TRANSPLANT PATIENTS WITH ESTABLISHED RECURRENT HEPATITIS C: INTERIM ANALYSIS  
C Duvoux. Abstract 1.

CONVERSION OF LIVER TRANSPLANT RECIPIENTS WITH HEPATITIS B VIRUS FROM HEPATITIS B IMMUNE GLOBULIN (HBIG) AND LAMIVUDINE (LAM) TO ADEFOVIR DIPIVOXIL (ADV) AND LAM
W Neff. Abstract 505.

THE FIVE YEAR FOLLOW-UP OF A RANDOMIZED STUDY COMPARING LAMIVUDINE WITH LAMIVUDINE+HBIG INVESTIGATING THE PREVENTION OF HBV RECURRENCE AFTER LIVER TRANSPLANTATION.
M Buti. Abstract 129.                  

FEMALE HCV CIRRHOSIS LIVER TRANSPLANT RECIPIENTS HAVE WORSE FIBROSIS PROGRESSION DUE TO RECURRENT HCV THAN MALE HCV RECIPIENTS.
E Cholongitas. Abstract 131.

RISKS AND BENEFIT OF DIAGNOSTIC OF BIOPSY OF LIVER LESIONS BEFORE LIVER TRANSPLANTATION.
J I Herrero. Abstract 260.

ANTIVIRAL THERAPY OF PATIENTS WITH DECOMPENSATED CIRRHOSIS TO PREVENT HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION.
E Martínez-Bauer. Abstract 150